Assessing the role of insulin‐like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels - CEA - Commissariat à l’énergie atomique et aux énergies alternatives Accéder directement au contenu
Article Dans Une Revue International Journal of Cancer Année : 2016

Assessing the role of insulin‐like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels

Tom Palmer
  • Fonction : Auteur
Freddie C Hamdy
  • Fonction : Auteur
Zsofia Kote‐jarai
  • Fonction : Auteur
Ali Amin Al Olama
  • Fonction : Auteur
Kay‐tee Khaw
  • Fonction : Auteur
Janet L Stanford
  • Fonction : Auteur
William J Blot
  • Fonction : Auteur
Stephen Thibodeau
  • Fonction : Auteur
Adam S Kibel
  • Fonction : Auteur
Cezary Cybulski
  • Fonction : Auteur
Lisa Cannon‐albright
  • Fonction : Auteur
Jong Park
  • Fonction : Auteur
Radka Kaneva
  • Fonction : Auteur
Jyotsna Batra
  • Fonction : Auteur
Manuel R Teixeira
  • Fonction : Auteur
Hardev Pandha
  • Fonction : Auteur

Résumé

Circulating insulin‐like growth factors (IGFs) and their binding proteins (IGFBPs) are associated with prostate cancer. Using genetic variants as instruments for IGF peptides, we investigated whether these associations are likely to be causal. We identified from the literature 56 single nucleotide polymorphisms (SNPs) in the IGF axis previously associated with biomarker levels (8 from a genome‐wide association study [GWAS] and 48 in reported candidate genes). In ∼700 men without prostate cancer and two replication cohorts ( N ∼ 900 and ∼9,000), we examined the properties of these SNPS as instrumental variables (IVs) for IGF‐I, IGF‐II, IGFBP‐2 and IGFBP‐3. Those confirmed as strong IVs were tested for association with prostate cancer risk, low (< 7) vs . high (≥ 7) Gleason grade, localised vs . advanced stage, and mortality, in 22,936 controls and 22,992 cases. IV analysis was used in an attempt to estimate the causal effect of circulating IGF peptides on prostate cancer. Published SNPs in the IGFBP1/IGFBP3 gene region, particularly rs11977526, were strong instruments for IGF‐II and IGFBP‐3, less so for IGF‐I. Rs11977526 was associated with high ( vs . low) Gleason grade (OR per IGF‐II/IGFBP‐3 level‐raising allele 1.05; 95% CI: 1.00, 1.10). Using rs11977526 as an IV we estimated the causal effect of a one SD increase in IGF‐II (∼265 ng/mL) on risk of high vs . low grade disease as 1.14 (95% CI: 1.00, 1.31). Because of the potential for pleiotropy of the genetic instruments, these findings can only causally implicate the IGF pathway in general, not any one specific biomarker.
Fichier principal
Vignette du fichier
Intl Journal of Cancer - 2016 - Bonilla - Assessing the role of insulin‐like growth factors and binding proteins in.pdf (231.89 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Licence : CC BY - Paternité

Dates et versions

cea-04551327 , version 1 (18-04-2024)

Licence

Paternité

Identifiants

Citer

Carolina Bonilla, Sarah J Lewis, Mari‐anne Rowlands, Tom R Gaunt, George Davey Smith, et al.. Assessing the role of insulin‐like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels. International Journal of Cancer, 2016, 139 (7), pp.1520 - 1533. ⟨10.1002/ijc.30206⟩. ⟨cea-04551327⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More